KCM
AMGN icon

Kathmere Capital Management’s Amgen AMGN Stock Holding History

Kathmere Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.37M Sell
3,797
-185
-5% -$63.3K 0.07% 191
2026
Q1 		$1.4M Buy
3,982
+532
+15% +$190K 0.09% 160
2025
Q4 		$1.13M Buy
3,450
+228
+7% +$72.3K 0.08% 170
2025
Q3 		$909K Sell
3,222
-251
-7% -$72.8K 0.06% 187
2025
Q2 		$970K Sell
3,473
-1,067
-24% -$302K 0.07% 171
2025
Q1 		$1.41M Buy
4,540
+1,491
+49% +$440K 0.12% 118
2024
Q4 		$795K Sell
3,049
-62
-2% -$18.4K 0.07% 157
2024
Q3 		$1M Buy
3,111
+216
+7% +$70.7K 0.09% 132
2024
Q2 		$905K Buy
2,895
+280
+11% +$82.3K 0.1% 123
2024
Q1 		$743K Sell
2,615
-297
-10% -$86.9K 0.09% 130
2023
Q4 		$839K Sell
2,912
-476
-14% -$130K 0.11% 105
2023
Q3 		$911K Buy
3,388
+1,370
+68% +$342K 0.13% 87
2023
Q2 		$448K Sell
2,018
-3,164
-61% -$734K 0.07% 119
2023
Q1 		$1.25M Buy
5,182
+903
+21% +$222K 0.21% 61
2022
Q4 		$1.12M Buy
4,279
+982
+30% +$263K 0.2% 65
2022
Q3 		$743K Sell
3,297
-421
-11% -$102K 0.15% 73
2022
Q2 		$905K Buy
3,718
+610
+20% +$149K 0.17% 57
2022
Q1 		$752K Buy
3,108
+1,847
+146% +$424K 0.13% 63
2021
Q4 		$284K Sell
1,261
-572
-31% -$121K 0.05% 113
2021
Q3 		$390K Sell
1,833
-63
-3% -$14.5K 0.07% 85
2021
Q2 		$462K Hold
1,896
– – 0.09% 75
2021
Q1 		$472K Hold
1,896
– – 0.09% 69
2020
Q4 		$436K Hold
1,896
– – 0.09% 75
2020
Q3 		$482K Buy
+1,896
New +$470K 0.12% 60
2020
Q1 		– Sell
-1,211
Closed -$292K – 83
2019
Q4 		$292K Buy
+1,211
New +$267K 0.1% 78

Other funds holding AMGN

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Kathmere Capital Management's AMGN Position: Q2 2026 in Review

Kathmere Capital Management reduced its Amgen (AMGN) stake by 4.6% in Q2 2026, selling an estimated $63.3K and leaving 3,797 shares worth $1.37M. The position accounts for 0.07% of the portfolio, ranked #191.

Kathmere Capital Management first reported a position in AMGN in Q4 2019 and has held it in 25 quarters since. The position peaked at $1.41M in Q1 2025. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Kathmere Capital Management held 3,797 shares of Amgen worth $1.37M as of Q2 2026.
  • Kathmere Capital Management sold 185 Amgen shares in Q2 2026, an estimated $63.3K.
  • Amgen made up 0.07% of Kathmere Capital Management's portfolio in Q2 2026, its #191 holding.
  • Kathmere Capital Management first reported a position in Amgen in Q4 2019 and has held it in 25 quarters since.
  • Kathmere Capital Management's Amgen position peaked at $1.41M in Q1 2025.
  • 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Kathmere Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.